AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HIV (Human Immunodeficiency ... Read More
-
Shingles - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Shingles market report provides current treatment practices, emerging drugs, Shingles market share of the individual therapies, current and forecasted Shingles market Size from 2019 to 2032 ... Read More
-
Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032
... Immunodeficiency Virus Type-1 (HIV-1) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Human Immunodeficiency Virus Type-1 (HIV-1) market report provides current treatment practices, emerging drugs, Human ... Read More
-
Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2030
... Demand Analysis & Opportunity Outlook 2030 Market Overview Fatpos Global has released a report titled Women’s Health Diagnostics Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. ... Read More
-
Gonorrhea - Epidemiology Forecast - 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gonorrhea Understanding The DelveInsight Gonorrhea epidemiology report gives a ... Read More
-
Acquired Immunodeficiency Syndrome (AIDS) - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Acquired Immunodeficiency Syndrome ... Read More
-
Africa Condom Market, Size, Forecast 2022-2030, Industry Trends, Growth, Share, Impact of COVID-19, Opportunity Company Analysis
... to protect from SIT/ HIV diseases and unwanted pregnancies. In the Africa, most of countries are impoverished, and the awareness level of HIV/SIT diseases is negligible especially in its rural and semi-urban places. However the ... Read More
-
Genital Herpes - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Genital Herpes Understanding The DelveInsight Genital Herpes ... Read More
-
Herpes Simplex - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Simplex Understanding The DelveInsight Herpes Simplex ... Read More
-
Herpes Zoster - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Zoster Understanding The DelveInsight Herpes Zoster ... Read More
-
Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cytomegalovirus (CMV) Infection market report provides current treatment practices, emerging drugs, Cytomegalovirus (CMV) Infection market share of the individual therapies, ... Read More
-
HIV-associated Lipodystrophy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HIV-associated Lipodystrophy Understanding The DelveInsight HIV-associated Lipodystrophy ... Read More
-
Herpes Labialis - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Labialis Understanding The DelveInsight Herpes Labialis ... Read More
-
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage HIV ... Read More
-
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Multi-Drug-Resistant (MDR) Neisseria ... Read More
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2022
... development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule ... Read More
-
The World Market for Cancer Diagnostics, 2021
... cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity ... Read More
-
The World Market for Molecular Diagnostics Tests, 10th Edition
... indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various ... Read More
-
The Market for In Vitro Diagnostic Tests in Latin America
... (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are ... Read More
-
At-Home Testing: COVID-19 Trends and Future Potential
... disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
... growth of the worldwide market for molecular diagnostics in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
... preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as Zika ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years ... Read More
-
Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics)
... 35 million each year. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) analyzes the current and potential world market from 2018 to 2023 for tests and systems used to diagnose STDs. The key STDs ... Read More
Research Assistance
